Intellia Therapeutics Inc. (NTLA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2023 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 1,569,545 | 0.28 | |
| Q1 2023 | |||||
| ≡ | Viking Global Investors | Reduce 22.35% | 451,865 | 0.08 | |
| Q3 2022 | |||||
| ≡ | Viking Global Investors | Reduce 15.23% | 339,316 | 0.09 | |
| Q2 2022 | |||||
| ≡ | Viking Global Investors | Reduce 9.74% | 240,377 | 0.06 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.